COVID-19 has revealed that the world was not prepared for a pandemic that we had every reason to anticipate. Yet we neglected to adequately invest in developing and maintaining global health system resilience. Consequently, the COVID-19 pandemic should serve as a wake-up call to global leaders that is every bit as significant – and urgent – as the Global Financial Crisis of more than a decade ago and the worsening climate emergency of today.
As global leaders emerge from the COVID-19 pandemic, we must seize the opportunity to learn the lessons from this crisis, making it a catalyst for serious reforms – both for improving the health resilience of economies and for looking more deeply at the issue of healthier alongside cleaner growth.
The Reform for Resilience Commission (R4RX) was created to shape new models, metrics, and practical policy reforms to help leaders in the public and private sectors deliver the changes needed for healthier growth.
The Asia Pacific was successful in preserving public health and economic prosperity in 2020, piquing interest in how the region tracked, contained, and controlled the spread of COVID-19. However, the pandemic has posed systemic challenges to these societies that will change how public health, business, and environmental stewardship are conducted.
The Asia-Pacific Hub of the Reform for Resilience Commission housed at CAPRI collaborates with the Secretariat, the Americas Hub at the Harvard T.H. Chan School of Public Health, and international partners to spearhead the Resilience Commission’s research and networking.
At GHS2022 in Singapore, CAPRI joined Reform for Resilience’s co-chairs and hubs for their first in-person meeting, using the sidelines of the conference to align on strategy, research priorities, and convening.
We participated in the Healthcare System Resilience Summit at World Expo 2020 in Dubai. The CAPRI leadership together with experts and leaders worldwide discussed learnings from the pandemic and key innovations for recovery and resilience of healthcare systems.
With the arrival of the Omicron variant, news outlets have exploded into a discussion about the dangers of vaccine inequity. Many experts have pointed to the fact
CAPRI partnered with organizations from Europe, Taiwan, and the US to host a webinar, wherein 14 experts examined the triple challenge of vaccine development, distribution, and acceptance worldwide. Marking the launch of CAPRI’s “Vaccines and the ‘Triple Challenge’” report, the event highlighted innovative policy and private-sector solutions to strengthen health system resilience.
Developed for a broad global audience, this report focuses on vaccines as key to resilience in the Asia Pacific. In what is still a fast-moving environment, this report draws on interviews with regional experts and additional research in late 2021 to identify factors in the Asia Pacific that have affected vaccine equity and rollout during the pandemic and actions that will contribute to resilience in the future.
Building on insights from the Commission’s first summit in November 2020 and an initial call for evidence, the Commission released its Call for Evidence in
Although vaccine development has been remarkable during the pandemic, at both national and international level, there have been significant challenges in manufacturing, vaccine rollouts and
At GHS2022 in Singapore, CAPRI joined Reform for Resilience’s co-chairs and hubs for their first in-person meeting, using the sidelines of the conference to align on strategy, research priorities, and convening.
We participated in the Healthcare System Resilience Summit at World Expo 2020 in Dubai. The CAPRI leadership together with experts and leaders worldwide discussed learnings from the pandemic and key innovations for recovery and resilience of healthcare systems.
With the arrival of the Omicron variant, news outlets have exploded into a discussion about the dangers of vaccine inequity. Many experts have pointed to the fact
CAPRI partnered with organizations from Europe, Taiwan, and the US to host a webinar, wherein 14 experts examined the triple challenge of vaccine development, distribution, and acceptance worldwide. Marking the launch of CAPRI’s “Vaccines and the ‘Triple Challenge’” report, the event highlighted innovative policy and private-sector solutions to strengthen health system resilience.
Developed for a broad global audience, this report focuses on vaccines as key to resilience in the Asia Pacific. In what is still a fast-moving environment, this report draws on interviews with regional experts and additional research in late 2021 to identify factors in the Asia Pacific that have affected vaccine equity and rollout during the pandemic and actions that will contribute to resilience in the future.
Building on insights from the Commission’s first summit in November 2020 and an initial call for evidence, the Commission released its Call for Evidence in
Although vaccine development has been remarkable during the pandemic, at both national and international level, there have been significant challenges in manufacturing, vaccine rollouts and
